DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Pancytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pancytopenia ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin where reactions include pancytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Ribavirin side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-21

Patient: female, weighing 72.0 kg (158.4 pounds)

Reactions: Pancytopenia, Condition Aggravated, Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-08
    End date: 2011-07-08

Ribavirin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-08
    End date: 2011-07-08

Other drugs received by patient: Quetiapine Fumarate



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-14

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Alopecia, Dehydration, Pancytopenia, Neutropenia

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-25

PEG-Intron
    Dosage: 150 microgram, unk
    Start date: 2011-12-27

Ribavirin
    Dosage: 1200 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Rosuvastatin; Ramipril; Glucazide; Oxazepam; Premarin; Metformin HCL



Possible Ribavirin side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: 61 year old female, weighing 53.1 kg (116.8 pounds)

Reactions: Medical Diet, Malnutrition, Dehydration, Pancytopenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Boceprevir 200 MG Merck
    Dosage: 2400 mg tid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-02-10

Pegasys
    Dosage: 180mcg sq weekly
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-02-10

Ribavirin
    Dosage: 1000mg po daily
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-03
    End date: 2012-02-10



Possible Ribavirin side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: 59 year old male, weighing 120.7 kg (265.4 pounds)

Reactions: Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Telaprevir 375 MG Vertex
    Dosage: 2 tab tid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-22
    End date: 2012-02-01

Pegasys
    Dosage: 180mcg sq weekly other
    Indication: Hepatitis C
    Start date: 2011-11-22
    End date: 2012-02-01

Ribavirin
    Dosage: 1200mg po daily other
    Indication: Hepatitis C
    Start date: 2011-11-22
    End date: 2012-02-01



Possible Ribavirin side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: 57 year old female, weighing 79.4 kg (174.6 pounds)

Reactions: Large Intestinal Ulcer, Rectal Ulcer, Rectal Haemorrhage, Haemorrhoids, Pancytopenia, Blood Product Transfusion Dependent, Lower Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Telaprevir 375 MG Vertex
    Dosage: 375 mg tablets tid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-21

Ribavirin
    Dosage: 1200 mg po daily
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-21

Pegasys
    Dosage: 180 mcg sq weekly
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-21



Possible Ribavirin side effects in 40 year old male

Reported by a physician from Pakistan on 2012-08-01

Patient: 40 year old male

Reactions: Enterococcal Bacteraemia, Hepatitis Cholestatic, Complications of Transplanted Kidney, Hepatitis C, Transplant Rejection, Pancytopenia

Drug(s) suspected as cause:
Prednisolone
    Indication: Renal Transplant

Interferon Alpha 2A
    Indication: Hepatitis Cholestatic

Azathioprine
    Indication: Renal Transplant

Ribavirin
    Dosage: 400 mg
    Indication: Hepatitis Cholestatic

Ursodiol
    Indication: Liver Function Test Abnormal

Cyclosporine
    Indication: Renal Transplant



Possible Ribavirin side effects in 25 year old male

Reported by a health professional (non-physician/pharmacist) from Pakistan on 2012-08-01

Patient: 25 year old male

Reactions: Graft Dysfunction, Diarrhoea, Hepatitis C, Urinary Tract Infection, Cholestasis, Pancytopenia, Varices Oesophageal

Drug(s) suspected as cause:
Cyclosporine
    Indication: Renal Transplant

Peginterferon Alfa-2B
    Indication: Hepatitis Cholestatic

Ribavirin
    Dosage: 400 mg
    Indication: Hepatitis Cholestatic

Azathioprine
    Indication: Renal Transplant

Ursodiol
    Indication: Liver Function Test Abnormal

Prednisolone
    Indication: Renal Transplant



Possible Ribavirin side effects in 58 year old male

Reported by a physician from United States on 2012-07-31

Patient: 58 year old male

Reactions: White Blood Cell Count Decreased, Agitation, Waxy Flexibility, Restlessness, Mutism, Alanine Aminotransferase Increased, Pancytopenia, Stupor, Eating Disorder, Irritability, Aspartate Aminotransferase Increased, Platelet Count Decreased, Musculoskeletal Stiffness, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: daily (1200 mg), oral
    Administration route: Oral
    Indication: Hepatitis C

Peginterferon Alfa-2B
    Dosage: weekly (150 mcg), subcutaneous
    Indication: Hepatitis C

Other drugs received by patient: Acetaminophen; Vitamin D; Sildenafil Citrate



Possible Ribavirin side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: 53 year old male

Reactions: Pancytopenia

Drug(s) suspected as cause:
Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 150 mcg, qw
    Indication: Hepatitis C
    Start date: 2011-09-01

PEG-Intron
    Dosage: 150 mcg, qw
    Indication: Hepatitis C
    Start date: 2011-09-01

Other drugs received by patient: Prilosec; Tricor; Hyzaar



Possible Ribavirin side effects in 37 year old female

Reported by a physician from Brazil on 2012-07-03

Patient: 37 year old female, weighing 66.3 kg (145.9 pounds)

Reactions: Anaemia, Pancytopenia, Fibromyalgia, Apparent Life Threatening Event, Depression, Acute Respiratory Failure, Septic Shock, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 500 mg;q12h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-05-27

Victrelis
    Dosage: 800 mcg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-05-27

PEG-Intron
    Dosage: 80 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-05-27

Other drugs received by patient: Clonazepam; Sertraline Hydrochloride



Possible Ribavirin side effects in 24 year old female

Reported by a individual with unspecified qualification from Portugal on 2012-05-29

Patient: 24 year old female

Reactions: Maternal Exposure During Pregnancy, Pancytopenia, Abortion Spontaneous, Respiratory Tract Infection

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2006-02-17

Ribavirin
    Indication: Hepatitis C
    Start date: 2006-02-17



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-14

Patient: male, weighing 70.2 kg (154.4 pounds)

Reactions: Diarrhoea, Anaemia, Pancytopenia, Urosepsis, Hyponatraemia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-08
    End date: 2012-04-17

Pegasys
    Indication: Hepatitis C
    Start date: 2011-03-08
    End date: 2012-04-17

Neupogen
    Indication: Neutropenia
    Start date: 2011-10-11

Pegasys

Other drugs received by patient: Tramadol Hydrochloride; Nexium



Possible Ribavirin side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-05-11

Patient: 52 year old female

Reactions: Death, Sepsis, Anaemia, Pancytopenia, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Incivek
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in 58 year old female

Reported by a physician from Singapore on 2012-05-02

Patient: 58 year old female

Reactions: White Blood Cell Count Decreased, Confusional State, Pancytopenia, Hyponatraemia, Somnolence, Hypokalaemia, Haemoglobin Decreased, Face Oedema, Hepatic Encephalopathy, RED Blood Cell Count Decreased, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180;135 mcg, qw, sc
    Indication: Hepatitis C
    Start date: 2011-09-03
    End date: 2012-03-10

Pegasys
    Dosage: 180;135 mcg, qw, sc
    Indication: Hepatitis C
    End date: 2012-03-17

Pegasys
    Dosage: 180;135 mcg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-03-24

Boceprevir (Sch-503034)
    Dosage: 2400 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-01

Ribavirin
    Dosage: 1000 mg, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-03

Other drugs received by patient: Perindopril Erbumine; Unasyn; Lasix; Ciprofloxacin; Hepa-Merz



Possible Ribavirin side effects in 49 year old male

Reported by a physician from United States on 2012-04-27

Patient: 49 year old male, weighing 86.0 kg (189.2 pounds)

Reactions: Dyspnoea, Anaemia, Pancytopenia, Eczema, Pyrexia, Hyperhidrosis, Pallor, Fatigue, Malaise, Xerosis, Sputum Discoloured, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 300 mug, qwk
    Indication: Neutropenia
    Start date: 2011-11-01
    End date: 2011-11-17

Protease Inhibitors
    Dosage: 240 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-11
    End date: 2011-11-18

Epogen
    Dosage: unk unk, one time dose
    Indication: Hepatitis C

Ribavirin
    Dosage: 1200 mug, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-11
    End date: 2011-11-18

Darbepoetin Alfa
    Dosage: 200 mug/kg, qwk
    Indication: Hepatitis C
    Start date: 2011-11-19

Peginterferon Alfa
    Dosage: 135 mug, unk
    Indication: Hepatitis C
    Start date: 2011-10-11
    End date: 2011-11-15

Other drugs received by patient: Tylenol PM



Possible Ribavirin side effects in 39 year old male

Reported by a physician from Poland on 2012-04-20

Patient: 39 year old male

Reactions: Weight Decreased, Body Temperature Increased, Transaminases Increased, Hyperhidrosis, Pancreatic Disorder, Hepatomegaly, Oedema Peripheral, Bone Marrow Failure, Splenomegaly, Histiocytosis Haematophagic, B-Cell Lymphoma, Full Blood Count Abnormal, Febrile Neutropenia, Pancytopenia, Subclavian Vein Thrombosis, Ascites, Mucosal Erosion, Spleen Disorder, Bone Marrow Toxicity

Drug(s) suspected as cause:
Ribavirin
    Indication: Product Used FOR Unknown Indication

Interferon Alfa
    Indication: Product Used FOR Unknown Indication

Mabthera
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in 72 year old female

Reported by a physician from Japan on 2012-03-20

Patient: 72 year old female

Reactions: Glomerulonephritis Membranoproliferative, Pancytopenia, Pyrexia, Hypocomplementaemia, Haemodialysis, Ascites, Nephrotic Syndrome, Monoclonal Gammopathy, Oedema, Pleural Effusion, Cryoglobulins Present

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2009-09-01

Peginterferon Alfa-2B
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2010-01-01

Pegasys
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2010-01-01

Copegus
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2009-09-01



Possible Ribavirin side effects in 59 year old male

Reported by a pharmacist from United States on 2012-03-09

Patient: 59 year old male, weighing 94.5 kg (207.9 pounds)

Reactions: Pancytopenia

Drug(s) suspected as cause:
Ribavirin
    Dosage: mg every day po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-29

Boceprevir
    Dosage: mg po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-17



Possible Ribavirin side effects in male

Reported by a physician from Canada on 2012-03-08

Patient: male, weighing 93.3 kg (205.3 pounds)

Reactions: Hepatic Encephalopathy, Pollakiuria, Encephalopathy, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, qd
    Start date: 2011-06-29
    End date: 2011-08-10

Cyclosporine
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2011-02-12
    End date: 2011-09-21

Ribavirin
    Dosage: unk
    Start date: 2011-04-06

Peginterferon Alfa-2A
    Dosage: 180 mg qwk
    Start date: 2011-08-11
    End date: 2011-09-23

Cyclosporine
    Dosage: 75 mg, bid
    Indication: Liver Transplant
    Start date: 2011-02-08
    End date: 2011-02-11

Cyclosporine
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2011-09-22
    End date: 2011-10-18

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2011-08-15
    End date: 2011-10-18

Peginterferon Alfa-2A
    Dosage: 180 mg qwk
    Start date: 2011-04-06
    End date: 2011-08-03



Possible Ribavirin side effects in male

Reported by a physician from Canada on 2012-03-08

Patient: male, weighing 93.3 kg (205.3 pounds)

Reactions: Hepatic Encephalopathy, Pancytopenia, Encephalopathy, Pollakiuria

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, qd
    Start date: 2011-06-29
    End date: 2011-08-10

Peginterferon Alfa-2A
    Dosage: 180 mg qwk
    Start date: 2011-08-11
    End date: 2011-09-23

Cyclosporine
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2011-02-12
    End date: 2011-09-21

Cyclosporine
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2011-09-22
    End date: 2011-10-18

Cyclosporine
    Dosage: 75 mg, bid
    Indication: Liver Transplant
    Start date: 2011-02-08
    End date: 2011-02-11

Ribavirin
    Dosage: unk
    Start date: 2011-04-06

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2011-08-15
    End date: 2011-10-18

Peginterferon Alfa-2A
    Dosage: 180 mg qwk
    Start date: 2011-04-06
    End date: 2011-08-03



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from Australia on 2012-03-06

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Subarachnoid Haemorrhage, Nausea, Pancytopenia, Intracranial Aneurysm, Headache

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-14
    End date: 2011-12-20

Ribavirin
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-14
    End date: 2011-12-20



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-02-22

Patient: male, weighing 74.2 kg (163.2 pounds)

Reactions: Pancytopenia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
NO Treatment Received
    Dosage: unk
    Indication: Liver Transplant

Prograf
    Dosage: 1.5 mg, qd
    Indication: Liver Transplant
    Start date: 2005-07-25

Ribavirin
    Dosage: 600 mg, bid
    Indication: Hepatitis C
    Start date: 2011-03-21

Pegasys
    Dosage: 180 meq, qw
    Indication: Hepatitis C
    Start date: 2011-03-21



Possible Ribavirin side effects in

Reported by a physician from Korea, Republic of on 2012-02-14

Patient:

Reactions: Pruritus, Skin Reaction, Depression, Emotional Disorder, Vomiting, Nausea, Urinary Tract Infection, Pancytopenia, Rash, Peritoneal Tuberculosis, Haemoglobin Decreased, Iiird Nerve Paralysis, Diarrhoea, Sepsis, Alopecia, Gastrointestinal Disorder, Insomnia, Gastroenteritis, Thyroid Disorder, Platelet Count Decreased, Hyperthyroidism, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Peginterferon Alfa-2A
    Indication: Hepatitis C



Possible Ribavirin side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-02-08

Patient: 49 year old male

Reactions: Autoimmune Hepatitis, Pancytopenia

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Start date: 2005-05-01

Ribavirin
    Start date: 2005-05-01



Possible Ribavirin side effects in 58 year old male

Reported by a physician from France on 2012-01-27

Patient: 58 year old male

Reactions: Aplastic Anaemia, Pancytopenia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-03
    End date: 2012-01-03

Incivo
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-08
    End date: 2012-01-03

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-03
    End date: 2012-01-03



Possible Ribavirin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-18

Patient: female, weighing 200.5 kg (441.1 pounds)

Reactions: Weight Decreased, Cellulitis, Escherichia Urinary Tract Infection, Hypotension, Urinary Incontinence, Pancytopenia, Thermal Burn, Fatigue, Fungal Infection, Swelling, Vertigo, Oedema, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-07-25

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-07-25

Telaprevir
    Indication: Hepatitis C
    Start date: 2011-07-25



Possible Ribavirin side effects in male

Reported by a pharmacist from United States on 2012-01-12

Patient: male

Reactions: Fatigue, Vomiting, Diarrhoea, Nausea, Pancytopenia, Condition Aggravated, Bacterial Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180mcg qw sq
    Start date: 2011-10-19
    End date: 2011-12-28

Ribavirin
    Dosage: 400mg bid 09
    Administration route: Oral
    Start date: 2011-10-19
    End date: 2011-12-26



Possible Ribavirin side effects in 72 year old female

Reported by a physician from Japan on 2011-12-28

Patient: 72 year old female

Reactions: Pancytopenia, Pyrexia, Hypocomplementaemia, Ascites, Haemodialysis, Nephrotic Syndrome, Monoclonal Gammopathy, Oedema, Pleural Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2010-01-01

Ribavirin
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2009-09-01



Possible Ribavirin side effects in 49 year old male

Reported by a physician from United States on 2011-12-12

Patient: 49 year old male, weighing 86.0 kg (189.2 pounds)

Reactions: Dyspnoea, Anaemia, Pancytopenia, Eczema, Pyrexia, Hyperhidrosis, Pallor, Malaise, Fatigue, Xerosis, Sputum Discoloured, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 300 mug, qwk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-01
    End date: 2011-11-17

Darbepoetin Alfa
    Dosage: 200 mug/kg, qwk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-19

Protease Inhibitors
    Dosage: 240 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-11
    End date: 2011-11-18

Ribavirin
    Dosage: 1200 mug, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-11
    End date: 2011-11-18

Peginterferon Alfa-2A
    Dosage: 135 mug, unk
    Indication: Hepatitis C
    Start date: 2011-10-11
    End date: 2011-11-15

Epogen
    Dosage: unk unk, one time dose
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Tylenol PM



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2011-12-01

Patient: male, weighing 74.2 kg (163.2 pounds)

Reactions: Pancytopenia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 meq, qw
    Indication: Hepatitis C
    Start date: 2011-03-21

Ribavirin
    Dosage: 600 mg, bid
    Indication: Hepatitis C
    Start date: 2011-03-21

NO Treatment Received
    Dosage: unk
    Indication: Liver Transplant

Prograf
    Dosage: 1.5 mg, qd
    Indication: Liver Transplant
    Start date: 2005-07-25



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014